Canaccord Genuity Maintains Buy on Privia Health Gr, Lowers Price Target to $34

Benzinga Newsdesk www.benzinga.com Negative 63.3%

Neg 63.3% Neu 0% Pos 0%

Canaccord Genuity analyst Richard Close maintains Privia Health Gr (NASDAQ:PRVA) with a Buy and lowers the price target from $35 to $34.